Patents by Inventor Eric Delpire

Eric Delpire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070207140
    Abstract: KCC2, KCC3, and KCC4 potassium-chloride cotransporter proteins, and nucleic acid molecules encoding the same. Recombinant host cells, recombinant nucleic acids and recombinant proteins are also disclosed, along with methods of producing each. Isolated and purified antibodies to KCC2, KCC3, and KCC4 homologs, and methods of producing the same, are also disclosed. KCC2, KCC3, and KCC4 gene products have biological activity in potassium-chloride cotransport. Thus, therapeutic methods involving this activity are also disclosed.
    Type: Application
    Filed: December 12, 2006
    Publication date: September 6, 2007
    Applicant: Vanderbilt University
    Inventors: David Mount, Eric Delpire, Gerardo Gamba, Alfred George
  • Patent number: 7183075
    Abstract: KCC2, KCC3 and KCC4 potassium-chloride cotransporter proteins, and nucleic acid molecules encoding the same. Recombinant host cells, recombinant nucleic acids and recombinant proteins are also disclosed, along with methods of producing each. Isolated and purified antibodies to KCC2, KCC3 and KCC4 homologs, and methods of producing the same, are also disclosed. KCC2, KCC3 and KCC4 gene products have biological activity in potassium-chloride cotransport. Thus, therapeutic methods involving this activity are also disclosed.
    Type: Grant
    Filed: April 16, 2001
    Date of Patent: February 27, 2007
    Assignee: Vanderbilt University
    Inventors: David B. Mount, Eric Delpire, Gerardo Gamba, Alfred L. George, Jr.
  • Publication number: 20030027983
    Abstract: KCC2, KCC3 and KCC4 potassium-chloride cotransporter proteins, and nucleic acid molecules encoding the same. Recombinant host cells, recombinant nucleic acids and recombinant proteins are also disclosed, along with methods of producing each. Isolated and purified antibodies to KCC2, KCC3 and KCC4 homologs, and methods of producing the same, are also disclosed. KCC2, KCC3 and KCC4 gene products have biological activity in potassium-chloride cotransport. Thus, therapeutic methods involving this activity are also disclosed.
    Type: Application
    Filed: April 16, 2001
    Publication date: February 6, 2003
    Inventors: David B. Mount, Eric Delpire, Gerardo Gamba, Alfred L. George